Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high–molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma
Authors:
- 1 April 2011
- journal article
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 15 (2) , 108-116
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroidPathology, 2008
- Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroidDiagnostic Pathology, 2008
- Immunoexpression of HBME-1, High Molecular Weight Cytokeratin, Cytokeratin 19, Thyroid Transcription Factor-1, and E-cadherin in Thyroid CarcinomasJournal of Korean Medical Science, 2005
- Immunohistochemical Expression of Bcl-2, Ki-67, and p21 in Patients with Papillary Thyroid CancerTumor Biology, 2005
- Follicular Neoplasms of the ThyroidAdvances in Anatomic Pathology, 2004
- Immunohistochemical expression of cyclin D1, E2F‐1, and Ki‐67 in benign and malignant thyroid lesionsThe Journal of Pathology, 2002
- Immunohistochemical Diagnosis of Papillary Thyroid CarcinomaLaboratory Investigation, 2001
- Changing concepts in the pathogenesis and management of thyroid carcinomaCA: A Cancer Journal for Clinicians, 1996
- New antiserum against Ki-67 antigen suitable for double immunostaining of paraffin wax sections.Journal of Clinical Pathology, 1993
- Follicular neoplasms of the thyroid. A study of 44 cases followed for a minimum of 10 years, with emphasis on differential diagnosisCancer, 1984